Cite
HARVARD Citation
Klaassen, Z. et al. (2015). Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease?. Cancer. 121 (9), pp. 1414-1421. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Klaassen, Z. et al. (2015). Is clinical stage T2c prostate cancer an intermediate‐ or high‐risk disease?. Cancer. 121 (9), pp. 1414-1421. [Online].